SKI Market

A+| A| A-|

Indian Indices

Sensex

73,319.55 185.23
( 0.25%)

Global Indices

Nasdaq

46,525.67 -61.07
(-0.13%)

Dow Jones

6,603.69 7.37
(0.11%)

Hang Seng

53,162.49 699.22
(1.33%)

Nikkei 225

10,436.29 71.50
(0.69%)

Forex

USD-INR

93.02 -0.15
(-0.16%)

EUR-INR

107.32 -0.65
(-0.60%)

GBP-INR

123.03 -0.78
(-0.63%)

JPY-INR

0.58 0.00
(-0.67%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Bal Pharma Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524824

INE083D01012

62.7662681

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

BALPHARMA

11.77

101.91

EPS(TTM)

Face Value()

Div & Yield %

5.44

1.87

Back

Paul Merchants reports consolidated net loss of Rs 14.40 crore in the December 2025 quarter

Feb 13,2026

Net loss of Paul Merchants reported to Rs 14.40 crore in the quarter ended December 2025 as against net profit of Rs 17.72 crore during the previous quarter ended December 2024. Sales declined 32.70% to Rs 504.79 crore in the quarter ended December 2025 as against Rs 750.04 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	504.79	750.04	-33
OPM %	-0.63	-0.35	-
PBDT	12.18	-2.52	LP
PBT	10.56	-3.48	LP
NP	-14.40	17.72	PL

73,319.55 185.23 ( 0.25%)

46,525.67 -61.07 (-0.13%)

6,603.69 7.37 (0.11%)

53,162.49 699.22 (1.33%)

10,436.29 71.50 (0.69%)

93.02 -0.15 (-0.16%)

107.32 -0.65 (-0.60%)

123.03 -0.78 (-0.63%)

0.58 0.00 (-0.67%)